Li, Jie http://orcid.org/0000-0002-1059-280X
Canham, Stephen M. http://orcid.org/0000-0003-4750-8066
Wu, Hua
Henault, Martin
Chen, Lihao
Liu, Guoxun
Chen, Yu
Yu, Gary
Miller, Howard R.
Hornak, Viktor http://orcid.org/0000-0002-2344-9586
Brittain, Scott M.
Michaud, Gregory A. http://orcid.org/0000-0003-3954-4921
Tutter, Antonin
Broom, Wendy
Digan, Mary Ellen
McWhirter, Sarah M.
Sivick, Kelsey E. http://orcid.org/0000-0002-5050-3891
Pham, Helen T.
Chen, Christine H.
Tria, George S. http://orcid.org/0000-0001-8597-6130
McKenna, Jeffery M. http://orcid.org/0000-0002-2978-5652
Schirle, Markus http://orcid.org/0000-0003-4933-2623
Mao, Xiaohong
Nicholson, Thomas B. http://orcid.org/0000-0001-7555-9456
Wang, Yuan
Jenkins, Jeremy L. http://orcid.org/0000-0001-9795-0771
Jain, Rishi K.
Tallarico, John A. http://orcid.org/0000-0002-8040-8422
Patel, Sejal J.
Zheng, Lianxing
Ross, Nathan T.
Cho, Charles Y.
Zhang, Xuewu http://orcid.org/0000-0002-3634-6711
Bai, Xiao-Chen http://orcid.org/0000-0002-4234-5686
Feng, Yan http://orcid.org/0000-0003-2185-0234
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA273595, R01CA273595)
Welch Foundation (I-1702, I-1702)
Cancer Prevention and Research Institute of Texas (RP160082)
Article History
Received: 20 January 2023
Accepted: 2 September 2023
First Online: 12 October 2023
Competing interests
: All authors (except otherwise noted) are or were at the time of their involvement with the research employees of Novartis Institute for BioMedical Research and may hold stock in Novartis. S.M.M. and K.E.S. were at the time of their involvement with the research employees of Aduro Biotech and may hold stock in Aduro (now Chinook Therapeutics).